by John R. Fischer
, Senior Reporter | April 20, 2020
Medical imaging providers should expect changes in their supply chains, due to the impact of the China lockdown and a decrease in imaging unit shipments in H1. More opportunities for assembly and parts, however, are expected to be found in markets in Latin America and Eastern Europe.
Patient engagement and point-of-care testing
COVID-19 isolation has increased demand for engagement at home, which is partially responsible for the rise in telemedicine. Chronic disease cases and backlogs in elective procedures are anticipated to push OEMs to collaborate with providers on new patient management models.
Ad Statistics Times Displayed: 12577
Times Visited: 253
KA Imaging’s Reveal 35C detector, currently available as an upgrade solution in the US and selected geographies, can now be sold in the European Union. The detector recently obtained the CE Mark. Contact us at email@example.com to book a free demo.
Additional changes include the use of testing services at retail clinics and the adoption of home-based testing modalities.
"While we recognize the tragedy that COVID-19 has caused the world, we also realize that it has opened many opportunities for companies to rejuvenate in this 'new normal' ecosystem,” said Reenita Das, Transformational Health senior vice president and partner, Frost & Sullivan, in a statement.
Frost & Sullivan did not respond for comment. Back to HCB News